Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

ExpertiseUpdated on 30 March 2026

SPR characterization of innovative therapeutics

Cyril GILBERT

CEO at Kimialys

Paris, France

About

Kimialys leverages its proprietary chip functionalization technology to generate clear-cut and reliable SPR characterization data for innovative therapeutics and targets (VHHs, bispecifics, protein aggregates, GPCR, EVs) in any type of biological matrix (plasma, cell extract, and so forth).
We support biotech and big pharma across Europe and North America, carrying out SPR analyses on our own, or helping SPR teams achieve challenging experiments.

Organisation

Kimialys

SME

Paris, France

Similar opportunities